Jun Ye

8PUBLICATIONS
11CO-AUTHORS
Medical biochemistry - inorganic elements and compoundsPredictive and prognostic markersPreventative health careCancer diagnosisToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 09, 2025
Is Tailored Bismuth Quadruple Therapies (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First-Line Helicobacter pylori Eradication Treatment More Effective? A Three-Arm, Multicenter Randomized Clinical Trial.

Zhengchen Yu, Xiaochen Liu, Jincheng Qiao

|Jan 25, 2025
The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers.

Jincheng Qiao, Zhengchen Yu, Han Zhou

|Jul 21, 2023
Efficacy of quadruple therapy with clarithromycin based on faecal molecular antimicrobial susceptibility tests as first-line treatment for Helicobacter pylori infection: a protocol of a single-centre, single-blind, randomised clinical trial in China.

Yaoyi Wu, Yujing Wang, Xiaochen Liu

|Mar 07, 2023
Gastric microbiota in gastric cancer and precancerous stages: Mechanisms of carcinogenesis and clinical value.

Oulan Liao, Guanshui Ye, Qin Du

|Dec 02, 2022
Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial.

Lifen Lu, Yujing Wang, Jun Ye

|Sep 17, 2022
Short-term outcomes and intermediate-term follow-up of Helicobacter pylori infection treatment for naïve patients: a retrospective observational study.

Yujing Wang, Yu Xiang, Oulan Liao

Pageof 2

Frequent Collaborators

1 joint publications

Caihua Wang

1 joint publications

Chunpeng Zhu

1 joint publications

Liming Shao

1 joint publications

Yimin Shen